CLIA-Waived Drug Test Cups

CLIA-waived means the test is FDA-cleared and categorized as low complexity under the Clinical Laboratory Improvement Amendments, so it can be performed in waived settings — clinics, physician offices, and point-of-care programs — by following the manufacturer instructions. Waived tests are simple to perform and carry a low risk of erroneous results when used as directed.

Any facility operating under a CLIA Certificate of Waiver can perform waived testing: primary care and urgent care clinics, behavioral health and addiction treatment programs, school and occupational health departments, and community health centers. The facility must hold the certificate, train operators, and follow the package insert exactly.

Yes. A cup marketed as CLIA-waived has been cleared by the FDA for waived use. MayFlower’s 12 panel cup with PCP is CLIA-waived and FDA-cleared, with results in about 5 minutes and an integrated temperature strip for specimen validity.

Intended use and regulatory pathway. CLIA-waived cups are cleared for clinical point-of-care screening and diagnosis support. Forensic-use only (FUO) cups are for criminal justice and program testing — drug courts, probation, corrections — and are not cleared for clinical diagnosis. Programs must choose the device that matches their setting; see both the CLIA-waived and forensic-use collections.

Waived immunoassay cups are screening devices with accuracy comparable to laboratory immunoassay screens when the specimen is valid and the read time is observed. Results are preliminary: a non-negative result that will affect treatment, employment, or legal decisions should be confirmed by a certified laboratory using GC-MS or LC-MS/MS.

Yes. Waived sites must follow the manufacturer quality control instructions in the package insert — typically running external controls with each new lot or shipment and whenever results are questionable — and document QC and results as part of the site testing record. Good laboratory practice also includes temperature checks on every specimen.

Waived configurations cover the standard workplace analytes such as THC, cocaine, opiates, amphetamines, benzodiazepines, and PCP. The MayFlower CLIA-waived 12 panel cup with PCP combines clinical compliance with broad coverage in one device. Programs that need fentanyl, ETG, or kratom screening in a waived setting typically run the waived cup on site and send expanded-panel confirmations to a reference laboratory.

Results are read at about 5 minutes after collection, which is why waived cups are the standard for point-of-care decisions — intake assessments, treatment visits, and same-day clinical screening. The cup format integrates collection and testing, eliminating dip-card handling and reducing exposure and error.

The integrated temperature strip verifies the sample is within 90–100 °F (32–38 °C) shortly after collection, the first check against substitution or dilution. Waived sites also observe collection volume and appearance per the package insert. Invalid or questionable specimens should be recollected under site policy.

Clinics order by the case with tiered volume pricing, free shipping on 100+ cups, and same-day dispatch on stocked items. Keep inventory rotated by expiration date and stored at room temperature. See the wholesale drug test cups collection for case pricing across configurations.